Sex differences in angiotensin II-induced hypertension

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 5, 2007, Pages 727-734

  Xue, B ^b   Johnson, A K ^a,b,c   Hay, Meredith ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b E11 SSH   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Angiotensin II; Estrogen; Estrogen and receptors; Nitric oxide; Reactive oxygen species; Testosterone

Indexed keywords

ANDROGEN RECEPTOR; ANGIOTENSIN II; ESTROGEN RECEPTOR ALPHA; FLUTAMIDE; FREE RADICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; SEX HORMONE; SUPEROXIDE DISMUTASE; TEMPOL; TESTOSTERONE;

CHEMICAL INTERACTION; FEMALE; HYPERTENSION; INTRACELLULAR SPACE; MALE; MOUSE; NONHUMAN; OVARIECTOMY; PRESSOR RESPONSE; REVIEW; SEX DIFFERENCE; WILD TYPE;

ANIMALIA; MUS;

EID: 34248206085     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x2006005000093     Document Type: Review

References (59)

1. Messerli FH, Garavaglia GE, Schmieder RE, Sundgaard-Riise K, Nunez BD, Amodeo C. Disparate cardiovascular findings in men and women with essential hypertension. Ann Intern Med 1987; 107: 158-161.
2. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med 1991; 325: 756-762.
3. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313.
4. Staessen J, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. Arch Belg 1989; 47: 118-122.
5. Brosnihan KB, Li P, Ganten D, Ferrario CM. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. Am J Physiol 1997; 273: R1908-R1915.
6. Chen YF. Sexual dimorphism of hypertension. Curr Opin Nephrol Hypertens 1996; 5: 181-185.
7. Rowland NE, Fregly MJ. Role of gonadal hormones in hypertension in the Dahl salt-sensitive rat. Clin Exp Hypertens A 1992; 14: 367-375.
8. Fink GD, Bruner CA, Mangiapane ML. Area postrema is critical for angiotensin-induced hypertension in rats. Hypertension 1987; 9: 355-361.
9. Matsukawa S, Reid IA. Role of the area postrema in the modulation of the baroreflex control of heart rate by angiotensin II. Circ Res 1990; 67: 1462-1473.
10. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, et al. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 2003; 285: R117-R124.
11. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, et al. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 2002; 91: 1038-1045.
12. Strehlow K, Rotter S, Wassmann S, Adam O, Grohe C, Laufs K, et al. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 2003; 93: 170-177.
13. Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST. Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23: 38-44.
14. Hawk T, Zhang YQ, Rajakumar G, Day AL, Simpkins JW. Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats. Brain Res 1998; 796: 296-298.
15. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 1993; 7: 678-686.
16. Xue B, Gole H, Pamidimukkala J, Hay M. Role of the area postrema in angiotensin II modulation of baroreflex control of heart rate in conscious mice. Am J Physiol Heart Circ Physiol 2003; 284: H1003-H1007.
17. Fink GD. Long-term sympatho-excitatory effect of angiotensin II: a mechanism of spontaneous and renovascular hypertension. Clin Exp Pharmacol Physiol 1997; 24: 91-95.
18. Hendel MD, Collister JP. Contribution of the subfornical organ to angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 2005; 288: H680-H685.
19. De Luca LA Jr, Sugawara AM, Menani JV. Brain versus peripheral angiotensin II receptors in hypovolaemia: behavioural and cardiovascular implications. Clin Exp Pharmacol Physiol 2000; 27: 437-442.
20. Bealer SL. Anteroventral third ventricle periventricular tissue contributes to cardiac baroreflex responses. Clin Exp Pharmacol Physiol 2000; 27: 460-464.
21. Xue B, Pamidimukkala J, Hay M. Sex differences in the development of angiotensin II-induced hypertension in conscious mice. Am J Physiol Heart Circ Physiol 2005; 288: H2177-H2184.
22. Doursout MF, Chelly JE, Wouters P, Lawrence C, Liang YY, Buckley JP. Effect of gender in centrally induced angiotensin II hypertension in dogs. Hypertension 1990; 15: I-117-I-120.
23. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 2002; 53: 672-677.
24. Chen YF, Naftilan AJ, Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 1992; 19: 456-463.
25. Lim YK, Retnam L, Bhagavath B, Sethi SK, bin Ali A, Lim SK. Gonadal effects on plasma ACE activity in mice. Atherosclerosis 2002; 160: 311-316.
26. Kisley LR, Sakai RR, Fluharty SJ. Estrogen decreases hypothalamic angiotensin II AT1 receptor binding and mRNA in the female rat. Brain Res 1999; 844: 34-42.
27. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 2005; 308: 1583-1587.
28. Huang A, Kaley G. Gender-specific regulation of cardiovascular function: estrogen as key player. Microcirculation 2004; 11: 9-38.
29. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P, et al. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res 2002; 90: 1087-1092.
30. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002; 295: 505-508.
31. Saleh MC, Connell BJ, Saleh TM. Autonomic and cardiovascular reflex responses to central estrogen injection in ovariectomized female rats. Brain Res 2000; 879: 105-114.
32. Saleh TM, Connell BJ. Centrally mediated effect of 17beta-estradiol on parasympathetic tone in male rats. Am J Physiol 1999; 276: R474-R481.
33. Saleh TM, Connell BJ. 17beta-estradiol modulates baroreflex sensitivity and autonomic tone of female rats. J Auton Nerv Syst 2000; 80: 148-161.
34. Li Z, Hay M. 17-beta-estradiol modulation of area postrema potassium currents. J Neurophysiol 2000; 84: 1385-1391.
35. Pamidimukkala J, Hay M. 17beta-estradiol inhibits angiotensin II activation of area postrema neurons. Am J Physiol Heart Circ Physiol 2003; 285: H1515-H1520.
36. Xue B, Pamidimukkala J, Hay M. Role of estrogen receptor alpha in angiotensin II-induced hypertension in conscious female mice. FASEB J 2005; 19: A617 (Abstract).
37. Xue B, Johnson RF, Beltz T, Johnson AK, Hay M. Central estrogen attenuates ANG II-induced hypertension in ovariectomized female mice. Experimental Biology 2006. April 1-5; San Francisco. 2006. p 37. Late Breaking Abstract 164.
38. Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension 2001; 37: 1199-1208.
39. Harshfield GA, Alpert BS, Pulliam DA, Somes GW, Wilson DK. Ambulatory blood pressure recordings in children and adolescents. Pediatrics 1994; 94: 180-184.
40. Reckelhoff JF, Zhang H, Srivastava K. Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system. Hypertension 2000; 35: 480-483.
41. Ouchi Y, Share L, Crofton JT, Iitake K, Brooks DP. Sex difference in the development of deoxycorticosterone-salt hypertension in the rat. Hypertension 1987; 9: 172-177.
42. Reckelhoff JF, Zhang H, Srivastava K, Granger JP. Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 1999; 34: 920-923.
43. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res 2002; 53: 688-708.
44. Xue B, Skala K, Pamidimukkala J, Hay M. Androgens modulate angiotensin II-induced hypertension in conscious male mice. FASEB J 2004; 18: A649 (Abstract).
45. Mates JM, Perez-Gomez C, Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 1999; 32: 595-603.
46. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 2004; 95: 210-216.
47. Zimmerman MC, Davisson RL. Redox signaling in central neural regulation of cardiovascular function. Prog Biophys Mol Biol 2004; 84: 125-149.
48. Pamidimukkala J, Xue B, Hay M. Role of ROS in angiotensin II-activation of area postrema (AP) neurons and systemic hypertension. Experimental Biology 2004. April 17-21; Washington. 2004. p A103. Late Breaking Abstract 501.
49. Xue B, Zhao Y, Beltz T, Johnson RF, Johnson AK, Hay M. The effects of L-NAME and tempol in Ang II induced hypertension in male mice. FASEB J 2006; 20: A1207 (Abstract).
50. Zhao Y, Pamidimukkala J, Hay M. Angiotensin II evoked increases in reactive oxygen species in subfornical organ neurons in the living brain slice. FASEB J 2005; 19: A1291 (Abstract).
51. Vincent SR, Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 1992; 46: 755-784.
52. Patel KP, Li YF, Hirooka Y. Role of nitric oxide in central sympathetic outflow. Exp Biol Med 2001; 226: 814-824.
53. Hodgin JB, Knowles JW, Kim HS, Smithies O, Maeda N. Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice. J Clin Invest 2002; 109: 541-548.
54. Rachman IM, Unnerstall JR, Pfaff DW, Cohen RS. Regulation of neuronal nitric oxide synthase mRNA in lordosis-relevant neurons of the ventromedial hypothalamus following short-term estrogen treatment. Brain Res Mol Brain Res 1998; 59: 105-108.
55. Ceccatelli S, Grandison L, Scott RE, Pfaff DW, Kow LM. Estradiol regulation of nitric oxide synthase mRNAs in rat hypothalamus. Neuroendocrinology 1996; 64: 357-363.
56. Singh R, Pervin S, Shryne J, Gorski R, Chaudhuri G. Castration increases and androgens decrease nitric oxide synthase activity in the brain: physiologic implications. Proc Natl Acad Sci U S A 2000; 97: 3672-3677.
57. Xue B, Skala K, Pamidimukkala J, Hay M. Protective effect of central nitric oxide (NO) in angiotensin II-induced hypertension in conscious female mice. FASEB J 2005; 19: A617 (Abstract).
58. Wang YR, Yen CH, Sun YF, Laun YT. Gender-dependent response in blood pressure changes following the inhibition of nitric oxide synthase. Chin J Physiol 2003; 46: 91-94.
59. Darley-Usmar VM, McAndrew J, Patel R, Moellering D, Lincoln TM, Jo H, et al. Nitric oxide, free radicals and cell signalling in cardiovascular disease. Biochem Soc Trans 1997; 25: 925-929.